Efficacy and safety of flupentixol-melitracen in patients with refractory chronic cough: a randomised, double-blinded, placebo-controlled clinical trialResearch in context

Summary: Background: The antitussive potential of flupentixol-melitracen, an anti-anxiety and anti-depression compound, has been observed previously. We aimed to further evaluate its efficacy and safety in patients with refractory chronic cough (RCC) who were unresponsive to any other available tre...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Qiang Chen, Mengru Zhang, Li Zhang, Alimire Aierken, Ran Dong, Xianghuai Xu, Li Yu, Kefang Lai, Zhongmin Qiu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2025-08-01
Saila:EClinicalMedicine
Gaiak:
Anxiety
Depression
Flupentixol-melitracen
Placebo
Refractory chronic cough
Sarrera elektronikoa:http://www.sciencedirect.com/science/article/pii/S2589537025002998
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak